About ironwood pharmaceuticals inc. - IRWD
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
IRWD At a Glance
Ironwood Pharmaceuticals, Inc.
100 Summer Street
Boston, Massachusetts 02110
| Phone | 1-617-621-7722 | Revenue | 351.41M | |
| Industry | Pharmaceuticals: Major | Net Income | 880.00K | |
| Sector | Health Technology | Employees | 253 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
IRWD Valuation
| P/E Current | 30.959 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 805.455 |
| Price to Sales Ratio | 2.018 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 6.85 |
| Enterprise Value to EBITDA | 12.485 |
| Enterprise Value to Sales | 3.472 |
| Total Debt to Enterprise Value | 0.491 |
IRWD Efficiency
| Revenue/Employee | 1,388,972.332 |
| Income Per Employee | 3,478.261 |
| Receivables Turnover | 4.291 |
| Total Asset Turnover | 0.855 |
IRWD Liquidity
| Current Ratio | 4.695 |
| Quick Ratio | 4.695 |
| Cash Ratio | 2.28 |
IRWD Profitability
| Gross Margin | 99.428 |
| Operating Margin | 27.238 |
| Pretax Margin | 18.553 |
| Net Margin | 0.25 |
| Return on Assets | 0.214 |
| Return on Equity | N/A |
| Return on Total Capital | 0.295 |
| Return on Invested Capital | 0.381 |
IRWD Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 201.07 |
| Total Debt to Total Assets | 170.837 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 200.00 |